Effects of a Test Food for Improvement of Skin Function.
- Conditions
- /A(healthy adults)
- Registration Number
- JPRN-UMIN000034491
- Lead Sponsor
- TES Holdings Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 128
Not provided
[1]Individuals using medical products. [2]Individuals with skin disease, such as atopic dermatitis. [3]Individuals with strange skin conditions at measurement points. [4]Individuals who used a drug to treat a disease in the past 1 month (except temporal usage for pollenosis). [5]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, hematological and blood disease. [6]Individuals who contract or have a history of serious gastrointestinal disease. [7]Individuals with serious anemia. [8]Individuals who are sensitive to test product or other foods, and medical products. [9]Individuals who are or are possibly pregnant, or are lactating. [10]Individuals who have an addiction to alcohol or a mental illness. [11]Individuals who are a smoker. [12]Individuals with possible changes of life style during the test period. [13]Individuals who will develop seasonal allergy symptoms like hay fever and a drug. [14]Individuals who have severe menopausal symptoms. [15]Individuals who neglect skin care. [16]Individuals who cannot avoid daylight exposure during the test period. [17]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements containing similar composition with a test food in the past 3 months or will ingest those foods during the test period. [18]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. [19]Individuals who have a habit to use drug claiming to improve skin condition in the past 3 months. [20]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months. [21]Individuals who had been conducted an operation on the test spot. [22]Individuals who have a habit to use drug claiming to improve skin condition in the past 3 months. [23]Individuals judged inappropriate for the study by the principal.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method [1]Indexes for skin function (skin moisture content, transepidermal water loss) (Screening, Week 0, Week 4, Week 8, Week 12).
- Secondary Outcome Measures
Name Time Method *Secondary indexes [1]Skin viscoelasticity (Screening, Week 0, Week 4, Week 8, Week 12). [2]Observation for skin condition by dermatologists (Screening, Week 0, Week 4, Week 8, Week 12). [3]Peeling of horny cell layer (Week 0, Week 12). *Safety [1]Blood test (Screening, Week 0, Week 12). [2]Blood biochemical test (Screening, Week 0, Week 12). [3]Urine analysis (Screening, Week 0, Week 12). [4]Blood pressure, pulsation (Screening, Week 0, Week 4, Week 8, Week 12). [5]Weight, body fat percentage, BMI (Screening, Week 0, Week 4, Week 8, Week 12). [6]Doctor's questions (Screening, Week 0, Week 4, Week 8, Week 12). [7]Subject's diary (From the first day of ingestion of a test material to the last day of the test).